Le Lézard
Classified in: Health
Subjects: CHI, LAW, SVY, LEG, EXE, NTA

Health Canada hosts Partnership Symposium on Cannabis Public Education and Awareness in Ottawa


Representatives from federal, provincial and territorial governments, Indigenous groups, and health and other partner organizations discussed priority areas for action

OTTAWA, Nov. 10, 2017 /CNW/ - The Government of Canada introduced legislation to legalize, strictly regulate and restrict access to cannabis to keep it out of the hands of Canadian youth and the profits from criminals and organized crime. With this in mind, the Government is developing a sustained public education campaign to help ensure that factual, evidence-based information about the health and safety risks of cannabis is available to Canadians. Health Canada recognizes that collaborating with key stakeholders across the country is essential to reaching our target audiences and addressing specific regional needs.

Today, Health Canada hosted a one-day public education symposium with approximately 90 representatives from federal, provincial and territorial governments, Indigenous groups, and health and other partner organizations that play a role in raising awareness and educating Canadians about the health and safety risks of cannabis use.

Participants shared insights on successes, proven practices, and challenges in raising awareness and educating the public on risks to health and safety. These insights informed discussions on the development of evidence-based content for cannabis public education campaigns as well as tools and strategies to effectively reach target audiences. Participants also discussed priority areas for action and opportunities for partnerships in raising awareness and educating the public about the potential health and safety risks of cannabis use.

Quotes

"Making sure Canadians know the real facts about cannabis use is my priority. I am pleased to see continued close collaboration and support from national partners for this important undertaking. By working together, we can maximize the reach and impact of our efforts across Canada to educate Canadians, particularly youth and young adults, about the health and safety risks of cannabis use."

The Honourable Ginette Petitpas Taylor
Minister of Health

"Evidence shows that there are a range of health risks associated with cannabis use, with youth and pregnant women being particularly vulnerable to its harms. At today's partnership symposium, representatives from all levels of government and civil society discussed the importance of reaching Canadians with relevant and fact-based information. By aligning our efforts, we can ensure Canadians have consistent and quality information to help them make informed choices."

Dr. Theresa Tam
Chief Public Health Officer of Canada

Quick Facts

Associated Link
Government of Canada to invest in cannabis education and awareness

 

SOURCE Health Canada


These press releases may also interest you

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:30
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

at 16:20
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales...



News published on and distributed by: